Nivolumab in Children and Adults With Nasopharyngeal Carcinoma

NCT06019130 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Nasopharyngeal Cancer
Nasopharyngeal Neoplasms
Nasopharynx Cancer

Interventions

DRUG: Nivolumab
DRUG: Cisplatin
DRUG: 5-Fluorouracil
DRUG: Gemcitabine
RADIATION: Radiotherapy
DRUG: Interferon beta-1a
PROCEDURE: MRI
PROCEDURE: PET
BEHAVIORAL: Patient-Reported Outcomes

Sponsor

German Society for Pediatric Oncology and Hematology GPOH gGmbH

Collaborators

[object Object]